Azenta to Host GENEWIZ Week November 6-10, 2023

BURLINGTON, Mass., Oct. 19, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting GENEWIZ Week November 6-10, 2023. The weeklong event will feature various virtual educational workshops, exclusive promotions, and a special grant program to recognize excellence in genomics research.

Throughout the course of the week, the experts in areas including next generation sequencing (NGS), PCR technologies and gene synthesis (GS) will be uncovering the many ways genomics is shaping workflows to go from sample-to-insights and from synthetic design to biological constructs. Each virtual workshop will be followed by an interactive roundtable with Azenta experts and guest speakers.

Each day of GENEWIZ Week will feature a different workshop topic. Online registration is now open.

During GENEWIZ Week, the company will recognize excellence in genomics research through its grant program totaling over $40,000 in credits, including a $20,000 grant towards a Proteomics Olink project. This year, seven winners will be awarded a grant for use towards a GENEWIZ service, as well as a bonus grant for consumables. Abstract submissions are due by November 3, 2023 for consideration, and winners will be announced after GENEWIZ Week concludes.

"We are thrilled to bring back our annual GENEWIZ Week," stated Ginger Zhou, SVP & General Manager, GENEWIZ Multiomics and Synthesis Solutions. "This event is a highlight for the team, and we look forward to a week full of collaboration and opportunities to engage with our customers."

Visit the website, GENEWIZ Week, for more details as well as the most up-to-date information.

About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey and B Medical Systems.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
[email protected]

Sherry Dinsmore
[email protected]

SOURCE Azenta

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED